Levi A. Garraway, MD, PhD
Sr. Vice President, Global Development & Medical Affairs, Lilly Oncology
Eli Lilly and Company
Dr. Garraway is senior vice president of Global Development and Medical Affairs, for Eli Lilly and Company. Prior to joining Lilly, he was an associate professor at Harvard Medical School in the Department of Medical Oncology at Dana-Farber Cancer Institute, and a member of the Broad Institute. He was the inaugural director of the Center for Cancer Precision Medicine at Dana-Farber, Brigham and Women’s Hospital, and the Broad Institute. Dr. Garraway has made seminal research contributions in cancer genomics, drug resistance, and cancer precision medicine. His advances have guided therapeutic and precision medicine initiatives at cancer centers worldwide. In 2015, Dr. Garraway was selected as a Howard Hughes Medical Institute investigator. In 2016, Dr. Garraway was named to former Vice President Biden’s Blue Ribbon Panel to develop recommendations for the Cancer Moonshot Initiative.